World Patient Registry Software Market Report 2021
Dublin, April 29, 2021 (GLOBE NEWSWIRE) — The “Patient Registry Software Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Software, Database, Registry, Mode of Delivery, and Pricing Model and Geography” report has been added to ResearchAndMarkets.com’s offering.
Patient Registry Software Market was valued at US$ 930.06 million in 2019 and it is projected to reach US$ 2,426.58 million by 2027; it is expected to grow at a CAGR of 12.9% during 2020-2027.
Factors such as development of digital infrastructure in healthcare, and increase in use of patient registries are fueling the growth of the global patient registry software market. Furthermore, emergence of cloud-based patient registries is offering lucrative opportunities to market players. However, the threats of data breach are hindering the market growth.
Based on software, the patient registry software market is segmented into standalone and integrated. In 2019, the integrated segment accounted for the largest share of the market.
CEDARON, Dacima Software Inc., Evado Clinical, FIGmd Inc., IBM Corporation;, IQVIA Inc., LUMEDX, McKESSON CORPORATION, and Medstreaming, Open Text Corporation are among the key players operating in the patient registry software market.
These companies focus on partnerships, product launches, and collaborations to sustain their positions in the market.
For instance, in October 2019, OpenText has acquired Liaison Technologies, Inc. to further enhance OpenText’s offerings in the digital ecosystem and business-to-business integration solutions, application-to-application integration, and master data management capabilities.